Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantationApostolia-Maria Tsimberidou, Susan O'Brien, Issa Khouri, et al.Cancer|December 12, 2003
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaSusan M O'Brien, Hagop M Kantarjian, Deborah A Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatmentWilliam G Wierda, Susan O'Brien, Xuemei Wang, et al.Cancer|December 15, 2005
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimensWilliam Wierda, Susan O'brien, Stefan Faderl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemiaWilliam Wierda, Susan O'Brien, Sijin Wen, et al.Blood|February 15, 2007
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemiaWilliam G Wierda, Susan O'Brien, Xuemei Wang, et al.The Journal of Molecular Diagnostics : JMD|January 1, 2013
Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypesCarmen D Schweighofer, Kevin R Coombes, Tadeusz Majewski, et al.Blood|March 12, 2014
Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemiaLorenzo Falchi, Michael J Keating, Edith M Marom, et al.Pageof 7